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Abstract Background Recent studies have suggested that a chronic mfection with Hehcobacter pylon
might be an mdependent nsk factor for atherosclerosis However, a direct role m
atherogenesis is not plausible, since the bactermm has not been isolated from atherosclerotic
lesions An indirect mechanism that could link H pylori with atherosclerosis might be through
an mcrease m plasma homocysteine concentration caused by deficiencies of Vitamin B12 and
folate m plasma
Materials and methods In 150 female patients with penpheral artenal disease (PAD) and
m 412 healthy control women from a nation-wide population-based case-control study,
blood samples were collected to determme the antibody titre agamst H pylon and to measure
plasma homocysteine, folate and Vitamin B12 levels First, the odds ratio for PAD m women
with a positive antibody titre agamst H pylon was calculated and adjusted for homocysteine
level Secondly, mean concentrations of Vitamin B12, folate and homocysteine were compared
in healthy controls with a positive or negative antibody titre agamst H pylon Thirdly, the
relation between H pylon and PAD in mdividuals with a normal or high homocysteine level
was mvestigated
Results A positive immunoglobulm G antibody titre against H pylon was found in 42% of
the PAD patients and m 27% of the controls The age- and socio-economic-status (SES)
adjusted odds ratio for PAD was l 5 (95%CI, l 0-2 2) Additional adjustment for
homocysteine plasma concentration did not essentially change the odds ratio Secondly,
among the healthy controls, the homocysteine plasma concentration did not depend on the
immunoglobulm G titre, neither did the folate plasma concentration The concentration of
vitamm B12 was shghtly higher m women with a positive titre Thirdly, H pylori mfection
was a nsk factor for PAD in subjects with a normal homocysteine concentration [OR 2 0
(95%CI l 3-3 1)]
Conclusions This study shows a relationship between a positive immunoglobulm G
antibody titre against H pylori and PAD m young women Moreover, this study does not
support the hypothesis that H pylon mfection is related to atherosclerosis via an mcrease m
plasma homocysteine concentration
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Introduction
Recent studies have suggested that chromc mfections with
Chlamydia pneumomae, Helicobaaer fylon, or cytomegalovinas
(CMV) might be mdependent nsk factors for atherosclerosis
[1] A direct role of these mfections in the pathogenesis is
supported by the detection of C pneumomae and CMV m
diseased vessels [2-6] However, for H pylon a direct role
is less convmcmg since the bactenum has not yet been
isolated from atherosclerotic lesions [7] It has been hypo-
thesized that indirect mechamsms that could link H pylon
with atherosclerosis, might be through one of the convenüonal
nsk factors for atherosclerosis
In a recent meta-analysis, mvolvmg more than 10 000
patients, the relations between H pylon and the conven-
üonal nsk factors have been studied [8] Included nsk
factors were blood pressure, body mass index, plasma viscosity,
white cell count, lipid profile, fibrmogen, blood glucose,
and C reactive protein No strong relationships between
H pylon seropositivity and any of these vascular nsk factors
were found and therefore none of the studied nsk factors
can be considered äs a confounder or an mtermediate in
the relation between mfection with H pylon and athero-
sclerosis Surpnsmgly, plasma homocysteme concentraüon
was not mcluded Prospective and case-control studies have
shown that an elevated homocysteme concentration is an
mdependent risk factor for atherothrombotic vascular
disease [9]
One plausible pathway by which H pylon mfection could
be Imked to atherogenesis is via an increase in the homo-
cysteme concentration In detail, chromc gastritis caused
by H pylon mfection will negatively influence the uptake of
Vitamin B12, either through reduced acid Output leading
to malabsorption of food-bound vitamm B12 or through
decreased mtrmsic factor production [10,11] Moreover,
folate uptake could also be decreased Lucock et al [12]
have studied factors which affect the stabihty, and thus the
bioavailability, of dietary folates Based on their m vitro
expenments they conclude that patients with a normal
gastric juice pH but a low ascorbate acid concentration
or patients with a high gastric juice pH are hkely to have
reduced dietary folate bioavailability A gastric juice with an
increased pH which contains decreased ascorbate is
precisely the Situation precipitated by chromc mfection
As a result of decreased bioavailability or uptake capacity,
deficiencies may develop
One important pathway by which homocysteme is meta-
bohzed, is the remethylation cycle, m this reaction
homocysteme is converted mto methionme by methionme
synthase [9,13] This conversion is dependent on the pres-
ence of both Vitamin B12 and folate Pherefore, anyone with
a nutritional deficiency or with a malabsorption that has
led to low blood concentrations of folate or Vitamin B12, is at
increased nsk of hyperhomocystemaemia Homocysteme is
directly toxic to endothehal cells and impairs endothehum-
dependent vasodilatation [14] Thus, the possible role of
plasma homocysteme concentration äs an mtermediate in
the relation between H pylon mfection and atherosclerosis,
is a field for mvestigation
We hypothesize that chromc gastritis caused by H pylon,
results in malabsortion of Vitamin B12 and folate which will,
eventually, lead to an increase m the homocysteme concen-
tration We performed a case-control study to investigate if
the relation between H pylon and atherosclerosis might be
explained by an increased plasma homocysteme concentration
Methods
Study design
Analyses are performed within the framework of the RATIO
(Risk of ArtenalThrombosis In relation to Oral Contracep-
tives) study This multicentre, population-based case-control
study was conducted to investigate the relation between
vascular diseases (stroke, myocardial mfarction and penpheral
artenal disease) and oral contraceptive use among women
18-49 years of age m the Netherlands [15] The study
protocol was approved by the ethics committees of all the
participatmg hospitals
Patients with peripheral arterial disease (PAD)
Female patients were eligible if (i) they had been referred
to one of the five collaborating hospitals (see Acknowledge-
ments) between January 1990 and December 1999, (u) they
had an angiographically confirmed diagnosis of PAD, (in)
they were aged 18-49 years at the time of referral and (iv)
they gave informed consent PAD was considered if a
patient presented with typical Symptoms of mtermittent
claudication (crampmg pam in the lower leg(s) durmg
exercise) or with rest pain, nonhealing ulcers, or gangrene A
stenotic lesion of more than 50% reduction (angiography)
of the lumen m at least one major peripheral artery (distal
abdominal aorta, common ihac artery, mternal and external
ihac artery, femoral artery, pophteal artery, anterior and
postenor tibial artery, peroneal artery) was considered diag-
nostic for PAD Patients were excluded if they had a history
of cerebral or coronary heart disease, used folic acid, vitamm
B dietary Supplements, or were diagnosed with severe
hyperhomocystemaemia (> 100 μηιοί L"1) [13]
Controls
The group of population-based control women was
recruited by random digit diallmg (RDD), random phone
numbers (m a certam area) were dialled and households
were ascertamed for eligible mdividuals (female, aged 18-
49 years) who were subsequently asked to participate
[16,17] This method resulted m controls who were approx-
imately (5-year strata) the same age äs the patients and
who hved in the Service areas of the participatmg hospitals
Controls were excluded if they used folic acid, vitamm B
dietary Supplements, or were diagnosed with a severe hyper-
homocystemaemia (> 100 μπιοί L"1)
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Data collection
Between June 1998 and May 2000, all participants had their
blood pressure measured, nonfastmg venous blood samples
were taken and a structured questionnaire was completed
Blood pressure was measured semiautomatically by a
physician (OmronM.7 OMRON Healthcare GmbH,
Hamburg, Germany) at one time-pomt Serum or plasma
were stored at —80 °C until processed
Conventwnal nsk factors
Data obtamed from the questionnaire mcluded current
medication use and classical nsk factors [body mass mdex
(BMI), smokmg, history of hypercholesterolaemia, diabetes
and hypertension] We categorized smokers äs current, former,
or never A positive history of hypercholesterolaemia was
defined by the use of cholesterol-lowermg medication or a
serum total cholesterol > 5 0 mmol L"1 This definmon is
based on the consensus text for hpid-lowering therapy (the third
consensus 'Cholesterol' which was published m 1998 [18])
A positive history of diabetes was defined by the use
of glucose-lowermg medication or a (nonfastmg) serum
glucose > 11 0 mmol L"1 A positive history of hypertension
was defined by the use of antihypertensive drugs or a systolic
blood pressure > 160 mmHg or a diastolic blood pressure
> 95 mmHg The socio-economic Status (SES) was defined
äs low, mtermediate, or high and was determmed accordmg
to the highest level of education attended by the participant
Highest education level could be primary school (low SES),
secondary school (mtermediate SES) or higher education/
umversity (high SES)
Serum total cholesterol, high-density lipoprotem (HDL)
-cholesterol, tnglycende and glucose concentrations were
measured with a colonmetnc lest on a chnical analyser
(Röche/Hitachi 747, Mannheim, Germany) Low-desmty
lipoprotem (LDL)-cholesterol was calculated by the Fnede-
wald equation The plasma C reactive protein (CRP)
concentration was determmed by a commercial enzyme
immunoassay (EIA, CRP EAI HS, Kordia, Leusden, the
Netherlands) Sensitivity was 5 μg L"1 and mtra-assay and
mterassay coefficients of Variation were 5 2% and 7 5%,
respectively
All assays were performed by a single technician who was
unaware of the ongm of the samples (case or control)
Determination of homocysteine concentration
Non-fastmg blood samples were drawn from the antecubital
vein in 5-mL Stabilyte® (Monovette®) tubes for determma-
tion of homocysteine Withdrawal on acidic citrate is a good
alternative for blood tubes on crushed ice, when screening
patients in epidemiological field studies, because total
homocysteine (tHcy) concentrations stay stable for 6 h [19]
The Stabilyte® blood sample was centnfuged at 2000 r p m
for 10-15 mm, and the plasma was separated and stored
at -80 °C until analysis
The deterrmnation of plasma homocysteine concentra-
tion was carned out in the Laboratory of Paediatncs and
Neurology of the Umversity Medical Centre Nijmegen
by high-performance liquid chromatography (HPLC) The
HPLC sodium borohydride/monobromobimane (NaBH4/
mBrB) method used HaBH4 for reduction and mBrB for
denvatization essentially accordmg to Fiskerstrand et al
with cysteamme äs external Standard [20] A programmable
sample processor (Gilson 232-401 sample processor, Spectra
Physics 8800 solvent dehvery System and Spectra Physics
LC 304 fluorometer) was used for automated homocysteine
reduction, denvatization and sample injection Values for
plasma tHcy, expressed äs homocysteine concentration in
mmol L"1, mcluded the sum of free and bound forms of
homocysteine, homocystme, and homocysteine-cysteme
mixed disulphide Hyperhomocystemaemia was defined
äs a homocysteine concentration > ΙόμιηοΙΙΓ1 (90th
percenüle of the female control population)
Determination of immunoglobulm G antibodies to H pylon
The presence of immunoglobulm G (IgG) antibodies to
H pylon was determmed by the use of commercial EIA
Positivity was defined accordmg to the mstructions of the
manufacturer (Enzygnost® Αηιι-Hehcobacter pylon II/IgG,
Dade Behring, Marburg, Germany)
Determination of vitamm B12 andfolate concentrations
Vitamin B12 and folate concentrations were simultaneously
measured in the control group usmg a Standard radioassay
(Dualcount® SPB, DPC, Los Angeles, CA, USA) The
concentration vitamm B12 was expressed in pg mL~' and the
concentration of folate was expressed in ng mL~'
Statistical analysis
Mean or median values or proportions of cardiovascular nsk
factors were calculated To assess whether the relation
between H pylon and PAD was due to an increase m the
homocysteine concentration, three different analyses were
performed Firstly, the age- and SES-adjusted odds ratio for
PAD and H pylon was calculated and compared to the
homocysteme-adjusted odds ratio The mean homocysteine,
vitamm B12 and folate concentrations and the percentage
of mdividuals with hyperhomocystemaemia were compared
in women with positive and negative IgG antibody titre
agamst H pylon Thirdly, the age- and SES-adjusted odds
ratios for PAD were calculated in four subgroups accordmg
to the IgG antibody titre agamst H pylon (positive or
negative) and the homocysteine plasma concentration
(hyperhomocystemaemia or no hyperhomocystemaemia)
Results
Initially 212 PAD patients and 464 control women were
mcluded However, eight patients and five control women
were excluded because of a severe hyperhomocystemaemia
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Table l Charactensücs of PAD patients and control women
Age in years (mean + SD)
BMI in kg rrf2 (mean ± SD)





pnmary school or less
secondary school
higher education or umversity
History of hypercholesterolaemia m percentage (n)
Cholesterol in mmol L"1 (mean ± SD)
HDL-cholesterol in mmol L"1 (mean + SD)
Tnglycende m mmol L"1 (mean ± SD)
LDL-cholesterol in mmol L"1 (mean ± SD)
Ratio of cholesterol HDL-cholesterol (mean + SD)
History of diabetes melhtus^ m percentage (n)
Glucose in mmol L"1 (mean ± SD)
History of hypertension* m percentage («)
Mean systolic blood pressure m mmHg (mean ± SD)
Mean diastohc blood pressure in mmHg (mean ± SD)
Hyperhomocystemaemia5 in percentage (n)
Homocysteine in μηιοί L~' (mean + SD)
CRP m mg L"1 (median, quartiles)
Positive IgG antibody titre agamst H pylort m percentage (n)
PAD patients
(n- 150)









5 61 ±1 21
1 31 ±0 37














45 5 ± 7 9








5 38 ± 1 10
1 42 + 0 33
1 49 ± 0 90
3 29 ± 0 97
4 00 ±1 31
1 (4)





124 + 3 3
1 3 (0 5, 5 2)
27 (110)
Positive history of hypercholesterolaemia was defined äs use of hpid-Iowermg medication and/or cholesterol plasma concentration
>50 mmol L"1
^Positive history of diabetes was defined äs use of blood-glucose-lowermg medication and/or (nonfastmg) glucose plasma concentration
> 11 0 mmol L '
^Positive history of hypertension was defined äs the use of antihypertensives and/or systolic blood pressure > 160 mmHg and/or diastohc
BP > 90 mmHg
^Hyperhomocystemaemia was defined äs a homocysteme concentration > 16 μπιοί L ' (90th percentile of the control population)
(> 100 μιηοΐ L ') Of the remaming parücipants, 54
patients and 47 controls were excluded because they used
folic acid or vitamm B dietary Supplements Thus, m the
present analysis 150 PAD patients and 412 control women
were mcluded All cardiovascular nsk factors were more
prevalent m the group of PAD patients compared to the
control group (Table 1) The percentage of individuals clas-
sified äs suffenng from hyperhomocystemaemia, was statist-
ically sigmficantly higher m PAD patients [OR 2 6 (95%CI
l 6—43)] The mean homocysteme concentration was higher
in PAD patients [mean difference 0 9 (95%CI 0 2-1 7)]
A positive IgG antibody titre agamst H pylon was found
m 42% of the PAD patients compared to 27% of the
controls [crudeOR2 0 (95%CI l 3-2 0)] After adjustment
for age and SES the odds ratio decreased to l 5 (95%CI
l 0-2 2) (Table 2) Additional adjustment for homo-
cysteme plasma concentration, or for hyperhomocystemae-
mia, did not change the odds ratio essentially, both adjusted
odds ratlos were l 6 (95%CI l 0-2 4)
Table 3 shows that among controls the homocysteme
plasma concentration did not differ between subjects with
a positive or a negative IgG titre agamst H pylon [mean
difference -0 l (95%CI - 0 8 to 0 6)], neither did the folate
Table 2 Crude and adjusted odds ratlos (95%CI) for PAD in
women with a positive IgG antibody compared to women with a





Age (years) and SES
(low, middle, high)
Age (years) and SES




SES (low, middle, high) and
hyperhomocystemaemia (yes/no)
2 0 (l 3-2 9)
l 7 (l 1-2 6)
l 5 (l 0-2 2)
l 6 (l 0-2 4)
l 6 (l 0-2 4)
Hyperhomocystemaemia was defined äs a homocysteme
concentration > 16 μπιοί L~' (90th percentile of the control
population)
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Table 3 Prevalence of hyperhomocystemaerma, plasma total homocysteme, Vitamin B12 and folate concentration in a population based
sample of young women according to their antibody titre against H pylon
Hyperhomocystemaemia m percentage (n)
Homocysteme in μηιοί L~' (mean ± SD)
Vitamin B12 in pg mL~' (mean ± SD)
Folate m ng mL"1 (mean ± SD)
Antibody titre against H








12 3 (3 0)
412 (193)
8 0 (4 1)
Difference (95%CI)
0 9 (0 5-1 9)f
-0 1 (-0 8-0 6)
44 5 (4 0-85 1)
-02 (-1 1-07)
*Hyperhomocystemaemia was defined äs a homocysteme concentration > 16 μτηοΐ L ' (90th percentile of the control population)
ratio mstead of difference of the mean values
Table 4 Hyperhomocystemaemia and H pylon separate and






























1 7 (1 1-2 7)
2 7 (1 5-5 1)
2 6 (1 0-6 8)
Hyperhomocystemaemia was defined äs a homocysteme
concentration > 16 μτηοΐ L ' (90th percentile of the control
population)
^Adjusted for age and socio-economic Status (SES)
plasma concentration [mean difference -0 2 (95%CI -l l
to 0 7)] However, the concentration of Vitamin B12 in plasma
was higher m women with a positive titre compared to those
with a negative titre [mean difference 44 5 (95%CI4 0-85 1)]
The age- and SES-ad;usted odds ratios for PAD accord-
mg to the presence of hyperhomocystemaerma and to the
IgG antibody titre against H pylon are shown in Table 4
Individuais classified äs 'no hyperhomocystemaemia' but
who were seropositive against H pylon had a l 7-fold nsk
of PAD compared to subjects without hyperhomocystem-
aemia and a negative IgG antibody titre [OR l 7 (95%CI
l 1-27)] Seronegative individuals with hyperhomocystem-
aemia had a 2 7-fold nsk of PAD compared to the reference
group [OR 2 7 (95%CI l 1-5 1)] When subjects were
exposed to both nsk factors their nsk of PAD was increased
by a factor of 2 6 [OR 2 6 (95%CI l 0-6 8)]
Discussion
The results of the present study show that it is unlikely that
the homocysteme plasma concentration is an intermediate
between H pylon infection and PAD Firstly, Table 2 shows
that the age- and SES-adjusted odds ratio for PAD did not
change after additional adjustment for the homocysteme
plasma concentration or for hyperhomocystemaemia [OR
l 5 (95%CI l 0-2 2) vs OR l 6 (95%CI l 0-2 4)] If,
infection with H pylon had been Imked with PAD via an
mcrease m the homocysteme concentration, one would have
expected the odds ratio to decrease after adjustment for
the intermediate variable The age- and SES-adjusted odds
ratio, however, is lower than the crude odds ratio This indic-
ates that the relation between H pylon and PAD can partly
be explamed by the age difference and the discrepancy m
SES between the PAD patients and the control women
The odds ratios were adjusted for age and SES since these
variables are related to both H pylon infection and PAD
and therefore they are considered äs potential confounders
Other cardiovascular nsk factors are not proven to be related
to H pylon infection and therefore were not considered
Potential confounders
Secondly, Table 3 shows that there was no signmcant
difference m plasma homocysteme concentration between
H βν/σπ-infected and noninfected controls These results
contradict the hypothesis that H pylon infection mcreases
the plasma homocysteme concentration According to our
data, it is unlikely that infection with H pylon negatively
mfluences the uptake of folate and Vitamin B12, smce the
plasma concentrations m infected subfects are equally high
(folate) or even higher (vitamin B12) than the concentrations
in noninfected subjects Thirdly, Table 4 shows that H pylon
infection is a nsk factor for PAD m subjects with a normal
homocysteme concentration [OR l 7 (95%CI l 1-2 7)]
The hypothesis that H pylon and atherosclerosis might
be Imked by the homocysteme concentration has been
proposed previously [21-24] However, original data on this
hypothesis are very sparse In 1997, two letters were
published presenting data on the relation between H pylon
infection and homocysteme [25,26] The first letter
describes an analysis withm the framework of an earlier
prospective case-control study of H pylon infection, in
mcident cases of myocardial mfarction and controls withm
the Bntish Regional Heart Study [27] Withm the control
group (n = 118), the mean total homocysteme concentrations
were similar m subjects seropositive (n - 63) or seronegative
(n = 55) for H pylon (P =098) The second letter
describes the mean homocysteme concentrations in a
healthy population of 220 individuals, no sigmficant
difference was found between the group of 122 H pylon-
seropositive and the group of 98 seronegative subjects
More recenth/j Leung et al showed that homocysteme
concentration was not related to the presence of antibodies
against H pylon in 49 dyspeptic patients [28] Moreover,
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after successful eradication of the bactenum there was no
sigmficant reduction in the homocysteme concentration
measured after a follow-up penod of 24 weeks [28] If a link
between H pylon mfection and atherosclerosis exists, other
mechanisms should be responsible A possible mechanism
could be mediated through the circulating cytokmes
mduced by the infection, e g mterleukin-1, mterleukin-6
and tumour necrosis factor These cytokmes may activate
or exacerbate the mflammatory reactions m the vascular
endothelmm [29] Another possible mechanism is by an
mfection-mduced autoimmune response This mechanism
requires that the mfecting pathogen contams peptides
homologous to those present in the host protems The
immune response, although stimulated by and targeted to
pathogen antigens, also attacks host tissues contammg the
cross-reacting protems [30]
The present study has two clear advantages Firstly, the
size of the study population (150 PAD patients and 412
controls) is larger than those of earlier reported studies
which made it possible to provide more precise estimates of
the differences in concentrations between seropositive and
seronegative individuals Secondly, this study not only
describes the homocysteme concentration but also the
concentration of Vitamin B12 and folate, two Substrates that
are considered intermediates in the hypothetical relation
between H pylon and homocysteme The study population
consists of young women and it might be invalid to extra-
polate the results to individuals who do not belong to the
same domain For example, the relation between H pylon
and homocysteme in older individuals rmght be different
due to the possibility that chronic gastntis might be more
advanced m the elderly
Since m the present study nonfasting blood samples were
collected, the scatter of the concentrations that were meas-
ured is larger compared to a Situation where fastmg blood
samples were collected Therefore, a hmitation of nonfasting
blood samples could be that mmor differences in homo-
cysteme, Vitamin B12, or folate concentration are not
detected On the contrary, the rather large size of the study
population is in favour of detectmg small differences
Another issue might be that in this study plasma folate
concentration was used mstead of whole blood or erythro-
cyte folate concentration Although erythrocyte folate
concentration is considered a better mdicator of folate Status
than serum folate, the latter is the variable generally meas-
ured Moreover, a detailed analysis of 1259 consecutive
requests for folate assays from a smgle representative labor-
atory showed a significant correlation between serum and
erythrocyte folate levels (r= 0 49, P< 0 001) [31] These
results were moderated at a meetmg of haematologists
where a consensus was reached, the plasma folate assay
which can be combmed easily with the Vitamin B12 assay,
was considered the most appropnate screenmg test for folate
deficiency
Initially patients with kidney disease were not excluded
Since there is a link between renal failure and homocysteme
level it is possible that the effect of H pylon mfection on
homocysteme is masked because it is diluted by the effect
of kidney disease However, if we performed the analysis
again, excludmg all individuals (14 patients and one control)
with diabetes (which m time will favour kidney disease),
the results of our analyses did not change essentially
Although the year m which the patients were diagnosed
vaned between 1990 and 1999, all blood samples and ques-
tionnaires were collected during the last 2 years of that
penod It is possible that those patients that were diagnosed
earlier have adapted a more healthy dietary pattern and hfe
style after diagnosis To reduce the bias which is inherent
in this study design, we excluded all individuals who used
folic acid or Vitamin B Supplements Patients might also
have received medication to control nsk factors for PAD
To achieve a proper assessment of the nsk factors m all indi-
viduals at the moment of diagnosis, we used defimtions that
mcluded serum levels äs well äs the use of medication
Some participants with a positive IgG antibody titre
agamst H pylon, might not have suffered from a chromc
gastntis at the moment of blood withdrawal, it is possible
that the mfection and the mflammatory reactions m the
gastnc wall had already been resolved To evaluate whether
the results of our study are distorted by this phenomenon, we
have repeated the same analyses m the subgroup of indi-
viduals with a CRP concentration above the median value
(l 3 mg L"1), äs it is known that chronic H pylon mfection
is associated with an mcreased CRP concentration Agam,
the odds ratio for PAD m individuals with a positive IgG
antibody titre agamst H pylon compared to those with a
negative titre, did not change after adjustment for homo-
cysteme plasma concentration Also, no difference m the
mean homocysteme concentration between H pylon sero-
positive and seronegative control subjects, was found (data
not shown)
In this study, young (< 50 years) women were diagnosed
with a first mamfestation of atherosclerosis in the penpheral
artenal circulation The reasons why these women develop
PAD at such an early age is not clear Apart from H pylon
mfection, other factors presumably also contnbute to devel-
opment of PAD The high percentage of young female PAD
patients who smoked or had been smokmg (95%) is remark-
able Obviously, a smgle cause of premature PAD does not
exist and the condition should be considered äs a complex
and multifactonal process As has recently been stated for
venous thrombosis [32], it is likely that certam environmen-
tal factors mteract with one another or with one or more
genetic vanations, and thereby constitute the nsk of PAD
In conclusion, the results of this study do not confirm the
hypothesis that H pylon mfection mcreases the homo-
cysteme concentration and therefore, do not support the
putative link between H pylon mfection and atherosclerosis
via an mcrease of the homocysteme concentration
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